---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-003947"
form_type: "8-K"
ticker: "IOBTQ"
cik: "0001865494"
company_name: "IO Biotech, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:35:26.674034+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# IO Biotech presents at J.P. Morgan conference; confirms cash runway into Q4 2025

## Summary
- Company presenting at 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.
- Updated corporate presentation posted; confirms projected cash runway through Q4 2025.
- No new clinical data or financial results disclosed in the filing.

## SEC filing metadata
- accession: 0001193125-24-003947
- form_type: 8-K
- ticker: IOBTQ
- cik: 0001865494
- company_name: IO Biotech, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1865494/000119312524003947/0001193125-24-003947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1865494/000119312524003947/d805340d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-003947
- JSON: https://secwatch.observer/filing/0001193125-24-003947.json
- Plain text: https://secwatch.observer/filing/0001193125-24-003947.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.